Abstract:Wheezing is the cardinal symptom of asthma; its presence early in life, mostly caused by viral infections, is a major risk factor for the establishment of persistent or recurrent disease. Early‐life wheezing and asthma exacerbations are triggered by common respiratory viruses, mainly rhinoviruses (RV), and to a lesser extent, respiratory syncytial virus, parainfluenza, human metapneumovirus, coronaviruses, adenoviruses, influenza, and bocavirus. The excess presence of bacteria, several of which are part of the microbiome, has also been identified in association with wheezing and acute asthma exacerbations, including haemophilus influenza, streptococcus pneumoniae, moraxella catarrhalis, mycoplasma pneumoniae, and chlamydophila pneumonia. While it is not clear when asthma starts, its characteristics develop over time. Airway remodeling already appears between the ages of 1 and 3 years of age even prior to the presence of atopic inflammation or an asthma diagnosis. The role of genetic defect or variations hampering the airway epithelium in response to environmental stimuli and severe disease morbidity are now considered as major determinants for early structural changes. Repeated viral infections can induce and perpetuate airway hyperresponsiveness. Allergic sensitization, that often precedes infection‐induced wheezing, shifts inflammation toward type‐2, while common respiratory infections themselves promote type‐2 inflammation. Nevertheless, most children who wheeze with viral infections during infancy and during preschool years do not develop persistent asthma. Multiple factors, including illness severity, viral etiology, allergic sensitization, and the exposome, are associated with disease persistence. Here, we summarize current knowledge and developments in infection epidemiology of asthma in children, describing the known impact of each individual agent and mechanisms of transition from recurrent wheeze to asthma.

Role of atypical bacterial infection of the lung in predisposition/protection of asthma

Mycoplasma Pneumoniae and Bronchial Asthma

The change of asthma-associated immunological parameters in children with mycoplasma pneumoniae infection

Reasearch Progress on the Role of Neutrophils in Asthma

Mycobacterium-Induced Th1, Helminths-Induced Th2 Cells and the Potential Vaccine Candidates for Allergic Asthma: Imitation of Natural Infection

Host defense genes in asthma and sepsis and the role of the environment

Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis

Bacterial antigens and asthma: a comparative study of common respiratory pathogenic bacteria

Does lung microbiome play a causal or casual role in asthma?

The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma

Bacteria and viruses and their role in the preschool wheeze to asthma transition

The role of atopy in asthma development and persistence

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

The role of gut microbiome in the complex relationship between respiratory tract infection and asthma

Mycobacterium Bovis-Bacillus Calmette-Guerin and Asthma.

Childhood infections and the risk of asthma: a longitudinal study over 37 years

Dysbiosis of the gut and lung microbiome has a role in asthma

Relationship of Pneumocystis antibody responses to paediatric asthma severity

Microbes little helpers and suppliers for therapeutic asthma approaches

Microbiome diversity, intra-mucosal bacteria and immune integration within normal and asthmatic airway mucosa

Atopy and susceptibility to respiratory infections in children